Cost implications of closure of atrial septal defect

✍ Scribed by Sherri S. Baker; Martin P. O'Laughlin; James G. Jollis; J. Kevin Harrison; Stephen P. Sanders; Jennifer S. Li

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 60 KB
• Volume: 55
• Category: Article
• ISSN: 1522-1946
• DOI: 10.1002/ccd.10079

✦ Synopsis

Abstract

We sought to evaluate the relative cost of surgical and device closure of atrial septal defect. Device closure for atrial septal defects is becoming an alternative to surgical closure. We examined the hospital‐generated cost data in 13 patients who underwent surgical repair and 15 patients who underwent device closure of an atrial septal defects (ASD) or patent foramen ovale (PFO) during a prospective clinical trial of the device. The cost of device closure of ASD was $7,837 less on average than surgical closure when the cost of the occlusion device was excluded (device closure cost $7,397 ± $2,822, surgical closure cost $15,234 ± $3,851; P < 0.001). When adjusted for a 5% failure rate of device closure, the cost savings was $7,076. Device closure of ASD results in substantial hospital‐related cost savings that will be an important consideration once new devices are approved for clinical use. Cathet Cardiovasc Intervent 2002;55:83–87. © 2002 Wiley‐Liss, Inc.